To investigate if exogenous IL-1α would enhance immune cell activation in the presence of RT-exposed cancer cells in vitro, we co-cultured human PBMCs with RT (0–8 Gy)-exposed Cal-27 cells and treated the co-cultures with human recombinant IL-1α (rIL-1α). This evidence concerns the gene IL1A and cancer.